EHMT2 and cancer: Collectively, these data suggested that IL-8 released by pancreatic cancer cells stimulates PSC activation via paracrine mechanism and inhibition of G9a in cancer cells reduces IL-8 secretion, PSC activation, and matrix protein deposition.